Emergent BioSolutions Inc/ US29089Q1058 /
| 2024-04-19 9:59:50 PM | Chg. +0.18 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.05USD | +9.63% | 14,468 Turnover: 28,681.19 |
-Bid Size: - | -Ask Size: - | 105.97 mill.USD | - | - |
Assets
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 313.9790 | 331.8560 | 376.4480 | 407.2100 | 510.2000 | ||||||
| Intangible Assets | 58.3440 | 57.3750 | 33.8650 | 119.5970 | 761.6000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 513.0870 | 504.9800 | 459.8930 | 584.8170 | 1,608.6000 | ||||||
| Inventories | 65.6740 | 76.9360 | 74.0020 | 142.8120 | 205.8000 | ||||||
| Accounts Receivable | 58.8340 | 120.7670 | 138.4780 | 143.6530 | 262.5000 | ||||||
| Cash and Cash Equivalents | 280.4990 | 312.7950 | 271.5130 | 178.2920 | 112.2000 | ||||||
| Current Assets | 432.1750 | 538.6120 | 510.2180 | 485.3890 | 620.8000 | ||||||
| Total Assets | 945.2620 | 1,043.5920 | 970.1110 | 1,070.2060 | 2,229.4000 | ||||||
Liabilities
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 40.9300 | 45.9660 | 34.6490 | 41.7510 | 80.7000 | ||||||
| Long-term debt | 251 | 253 | 248.0940 | 13.4570 | 784.5000 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | - | 72 | ||||||
| Liabilities | 392.0610 | 383.5750 | 373.9060 | 157.8610 | 1,218.5000 | ||||||
| Share Capital | .0380 | .0400 | - | - | - | ||||||
| Total Equity | 553.2010 | 660.0170 | 596.2050 | 912.3450 | 1,010.9000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 945.2620 | 1,043.5920 | 970.1110 | 1,070.2060 | 2,229.4000 | ||||||
Income Statement
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 450.1380 | 522.7890 | 488.7820 | 560.8730 | 782.4000 | ||||||
| Depreciation (total) | - | - | - | - | 25 | ||||||
| Operating Result | 58.0560 | 96.0390 | 105.5220 | 124.2850 | 89.8000 | ||||||
| Interest Income | -7.9200 | -5.9510 | -6.5640 | -4.8370 | -9.9000 | ||||||
| Income Before Taxes | 53.0620 | 89.7690 | 99.2210 | 118.6330 | 81.5000 | ||||||
| Income Taxes | 16.3210 | 26.8990 | 36.6970 | 36.0390 | 18.8000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 36.7410 | 62.8700 | 51.7760 | 82.5940 | 62.7000 | ||||||
Per Share
Cash Flow
| 2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 112.3180 | 44.4590 | 53.4870 | 208.1390 | 41.8000 | ||||||
| Cash Flow from Investing Activities | -210.0520 | -45.4620 | -76.2570 | -249.9320 | -897.2000 | ||||||
| Cash Flow from Financing | 198.8740 | 33.4490 | -18.6410 | -51.4010 | 788.7000 | ||||||
| Decrease / Increase in Cash | 101.1610 | 32.2960 | -41.2820 | -93.2210 | -66.9000 | ||||||
| Employees | 1,280 | 1,292 | 1,098 | 1,256 | 1,705 | ||||||
